Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[A Dinosaur]

Here are the items to be discussed. The entire filing is 45 pages so I only copied the itinerary.

The proxy statement and annual report to shareholders are available at: http://material.proxyvote.com/85517P
The 2012 annual meeting of the shareholders of Star Scientific, Inc. (the “Company”) will be held at 9:30 A.M. on
December 14, 2012 in the Mayfair Court Room of the Westin Grand Hotel, 2350 M Street, NW, Washington, DC 20037 (the
“Annual Meeting”).
The proposals to be considered by the Company’s stockholders at the Annual Meeting are:
1. a proposal to elect six directors to the Company’s Board of Directors for one-year terms;
2. a proposal to approve an amendment to the Company’s Seventh Amended and Restated Certificate of
Incorporation to increase the total number of shares of common stock that the Company is authorized to issue
from 207,500,000 to 213,500,000;
3. a proposal to approve an amendment to the Company’s 2008 Incentive Award Plan to increase the number of
shares available for issuance from 14,900,000 to 16,900,000 shares;
4. a proposal to ratify the appointment of Cherry, Bekaert & Holland, L.L.P., as the Company’s independent
auditor to audit the Company’s 2012 financial statements;
5. a proposal to approve an advisory resolution on executive compensation; and
6. any other matters as may properly come before the Annual Meeting or any adjournments or postponements of
the Annual Meeting.
The Board of Directors of Star Scientific, Inc. recommends that you vote “FOR” Proposals 1, 2, 3, 4 and 5.

Dino